pramipexole has been researched along with sibutramine in 2 studies
Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (sibutramine) | Trials (sibutramine) | Recent Studies (post-2010) (sibutramine) |
---|---|---|---|---|---|
1,103 | 219 | 517 | 967 | 218 | 204 |
Protein | Taxonomy | pramipexole (IC50) | sibutramine (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 5.665 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.39 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 5.665 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.085 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.632 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for pramipexole and sibutramine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for pramipexole and sibutramine
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |